[no_toc] Study Review • Psychiatry • Evidence Interpretation Cannabis Use Disorder Psychiatric Risk: What This 2026 Study Actually Shows A careful review of a large new study comparing cannabis use disorder with...
`Cannabinoid Clinical Trials: Cannabis-Induced Psychosis Risk`
Clinical Takeaway A significant portion of patients diagnosed with cannabis-induced psychosis go on to develop schizophrenia spectrum or bipolar disorder, meaning this initial diagnosis should not be considered a benign or self-limiting...
`Cannabis-Induced Psychosis and Schizophrenia Risk: Key Evidence`
Clinical Takeaway A significant portion of patients diagnosed with cannabis-induced psychosis go on to develop schizophrenia spectrum or bipolar disorder, making early identification and close psychiatric follow-up critical. Clinicians should not assume...
Can the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure
WHY IT MATTERS: If you are pregnant or planning to become pregnant and currently use cannabis, this research underscores why having an honest, judgment-free conversation with your physician about timing, risks, and alternatives is essential for both your care and your baby’s long-term neurodevelopmental health. CLINICAL OVERVIEW: Emerging research is exploring how prenatal cannabis exposure may alter genetic markers in the placenta, particularly in pregnancies associated with low birth weight, and whether those placental changes could serve as early indicators of neurodevelopmental risk including schizophrenia. This builds on what we already know clinically about the endocannabinoid system’s critical role in fetal brain development and placental function.